Monthly Archives: March 2020

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 25, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allakos Inc. ("Allakos" or "the Company") (NASDAQ:ALLK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between August 5, 2019 and December 17, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before May 11, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Allakos failed to appropriately design the ENIGMA trial for its flagship drug, AK002. The Company engineered results for the trial by cherrypicking timeframes, among other actions. The Company's chosen endpoints for trial were superficial as compared to FDA guidance. The Company misreported the number of adverse incidents that occurred during the trial, while also failing to report key data from the trial. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Allakos, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 582522

INVESTOR DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Six Flags Entertainment Corporation and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 25, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Six Flags Entertainment Corporation ("Six Flags" or "the Company") (NYSE:SIX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between April 25, 2018 and January 9, 2020, inclusive (the ''Class Period'') are encouraged to contact the firm before April 13, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Six Flags suffered from park development delays in China with partner Riverside. The delays were not "short-term" by any reasonable definition; in fact, the delays were both long-term and material in nature. Riverside was in a state of severe financial distress and did not have the resources necessary to complete its projects with the Company. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Six Flags, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 582519

Sigma Labs Announces Virtual Format Change for 2020 Special Meeting of Stockholders

Special Meeting of Stockholders Shifted to Virtual Format Due to COVID-19 Pandemic Related Health Concerns

SANTA FE, NM / ACCESSWIRE / March 25, 2020 / Sigma Labs, Inc. (NASDAQ:SGLB) ("Sigma Labs" or the "Company"), a leading developer of quality assurance software for the commercial 3D printing industry, announced today that, due to the current situation regarding the public health impact of the COVID-19 pandemic and limitations within the state of New Mexico on all non-essential gatherings of individuals, the Company has changed the format of its special stockholders meeting from a physical in-person meeting to a virtual webcast, and invites stockholders to participate remotely.

The special stockholders meeting will be held at 10:00 a.m. Mountain time on March 27, 2020 via webcast. Please see below for full details:

Sigma Labs Virtual Special Stockholders Meeting

Date:

March 27, 2020

Time:

10:00 a.m. Mountain time

Webcast Link:

http://www.viewproxy.com/SigmaLabsInc/2020SM/vm/

Attending the Virtual Special Meeting

Both stockholders of record and stockholders who hold their shares in "street name" will need to register to be able to attend the Special Meeting via live audio webcast, submit their questions during the meeting and vote their shares electronically at the Special Meeting by following the instructions below.

If you are a stockholder of record, you must:

First register at http://www.viewproxy.com/SigmaLabsInc/2020SM by 11:59 p.m. (EDT) on March 26 2020. You will need to enter your name, phone number, virtual control number (included on your proxy card) and email address as part of the registration, following which, you will receive an email confirming your registration, as well as the password to attend the Special Meeting.

On the day of the Special Meeting, if you have properly registered, you may enter the Special Meeting by logging in using the password you received via email in your registration confirmation at http://www.viewproxy.com/SigmaLabsInc/2020SM/vm/ (you will need the virtual control number included on your proxy card).

If you wish to vote your shares electronically at the Special Meeting, you will need to visit www.AALvote.com/sglbsm during the Special Meeting while the polls are open (you will need the virtual control number included on your proxy card).

If your shares are held in a "street name," you must:

Obtain a legal proxy from your broker, bank or other nominee.

Register at http://www.viewproxy.com/SigmaLabsInc/2020SM by 11:59 p.m. (EDT) on March 26, 2020.

You will need to enter your name, phone number and email address, and provide a copy of the legal proxy (which may be uploaded to the registration website or sent via VirtualMeeting@viewproxy.com as part of the registration, following which, you will receive an email confirming your registration, your virtual control number, as well as the password to attend the Special Meeting.

Please note, if you do not provide a copy of the legal proxy, you may still attend the Special Meeting, but you will be unable to vote your shares electronically at the Special Meeting.

On the day of the Special Meeting, if you have properly registered, you may enter the Special Meeting by logging in using the password you received via email in your registration confirmation at http://www.viewproxy.com/SigmaLabsInc/2020SM/vm/ (you will need the virtual control number assigned to you in your registration confirmation email).

If you wish to vote your shares electronically at the Special Meeting, you will need to visit http://www.AALvote.com/sglbsm during the Special Meeting while the polls are open (you will need the virtual control number assigned to you in your registration confirmation email).

Technical Difficulties

We will have technicians ready to assist you with any technical difficulties you may have accessing the Special Meeting live audio webcast. Please be sure to check in by 9:30 a.m. (MDT) on March 27, 2020, the day of the Special Meeting, so we may address any technical difficulties before the Special Meeting live audio webcast begins. If you encounter any difficulties accessing the Special Meeting live audio webcast during the check-in or meeting time, please email VirtualMeeting@viewproxy.com or call 866-612-8937

Further information regarding this change to the format of the special meeting can be found in the proxy supplement filed by the Company with the Securities and Exchange Commission on March 25, 2020.

About Sigma Labs

Sigma Labs, Inc. (NASDAQ: SGLB) is a leading provider of quality assurance software to the commercial 3D printing industry under the PrintRite3D® brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time computer aided inspection (CAI) solutions known as PrintRite3D® for 3D advanced manufacturing technologies. Sigma Labs' advanced computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance mid-production, uniquely allowing errors to be corrected in real-time. For more information, please visit www.sigmalabsinc.com.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words "believe," "anticipate," "estimate," "expect," "intend," "plan," "project," "prospects," "outlook," and similar words or expressions, or future or conditional verbs such as "will," "should," "would," "may," and "could" are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company's forward-looking statements, please see the Company's Annual Report on Form 10-K (including but not limited to the discussion under "Risk Factors" therein) filed with the SEC on March 24, 2020 and which may be viewed at www.sec.gov.

Company/Proxy Contact:

Steven Gersten
Sigma Internal IR
investors@sigmalabsinc.com

Investor Contact:

Chris Tyson
Managing Director
MZ Group – MZ North America
949-491-8235
SGLB@mzgroup.us
www.mzgroup.us

SOURCE: Sigma Labs, Inc.

ReleaseID: 582513

CLASS ACTION UPDATE for WWE, JELD and TUP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / March 25, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

WWE Shareholders Click Here: https://www.zlk.com/pslra-1/world-wrestling-entertainment-inc-loss-form?prid=5802&wire=1
JELD Shareholders Click Here: https://www.zlk.com/pslra-1/jeld-wen-holding-inc-loss-form?prid=5802&wire=1
TUP Shareholders Click Here: https://www.zlk.com/pslra-1/tupperware-brands-corporation-loss-form?prid=5802&wire=1

* ADDITIONAL INFORMATION BELOW *

World Wrestling Entertainment, Inc. (NYSE:WWE)

WWE Lawsuit on behalf of: investors who purchased February 7, 2019 – February 5, 2020
Lead Plaintiff Deadline : May 5, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/world-wrestling-entertainment-inc-loss-form?prid=5802&wire=1

According to the filed complaint, during the class period, World Wrestling Entertainment, Inc. made materially false and/or misleading statements and/or failed to disclose that: Defendants perpetrated a fraudulent scheme which: (i) deceived the investing public regarding WWE's business and prospects; (ii) artificially inflated the price of WWE Class A common stock; (iii) permitted certain senior executives of WWE to sell more than $282 million worth of their personally held shares at fraud inflated prices; and (iv) caused the public to purchase WWE Class A common stock at artificially inflated prices.

Jeld-Wen Holding, Inc. (NYSE:JELD)

JELD Lawsuit on behalf of: investors who purchased January 26, 2017 – October 15, 2018
Lead Plaintiff Deadline : April 20, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/jeld-wen-holding-inc-loss-form?prid=5802&wire=1

According to the filed complaint, during the class period, Jeld-Wen Holding, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's products, including doors, did not compete against other manufacturers on price, contrary to Jeld-Wen's representations; (2) the market in which the Company sells its doors is not "highly competitive" as the Company claimed; (3) Jeld-Wen's strong margins and anticipated margin growth were not, as the Company claimed, attributed to changes they had made in Jeld-Wen's business operations and strategies; and (4) Jeld-Wen failed to disclose the Company's anti competitive conduct. Because of the foregoing, Defendants' statements about the Company's business, operations and prospects lacked a reasonable basis.

Tupperware Brands Corporation (NYSE:TUP)

TUP Lawsuit on behalf of: investors who purchased January 30, 2019 – February 24, 2020
Lead Plaintiff Deadline : April 27, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/tupperware-brands-corporation-loss-form?prid=5802&wire=1

According to the filed complaint, during the class period, Tupperware Brands Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) Tupperware lacked effective internal controls; (2) as a result, Tupperware would need to investigate the accounting and liabilities of one of its brands, Fuller Mexico; (3) consequently, Tupperware would be unable to timely file its annual report on Form 10-K for its fiscal year 2019; (4) Tupperware did not properly account for its accounts payable and accrued liabilities at Fuller Mexico; (5) Tupperware provided overvalued earnings per share guidance; (6) Tupperware would need relief from its $650 million Credit Agreement; and (7) as a result, defendants' public statements were materially false and/or misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 582524

INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Tivity Health, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 25, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tivity Health, Inc. ("Tivity" or "the Company") (NASDAQ:TVTY) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Tivity announced its fourth quarter and full-year 2019 financial results on February 19, 2020. The Company disclosed a fourth-quarter net loss of more than $323 million, a $137 million charge to goodwill, and a $240 million impairment charge to the Nutrisystem brand. The Company also admitted that CEO Donato Tramuto had resigned. Based on this news, shares of Tivity dropped by nearly 45.5% the next day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 582515

Lincare Statement Regarding COVID-19

CLEARWATER, FL / ACCESSWIRE / March 25, 2020 / Lincare, a subsidiary of Linde (NYSE:LIN; FWB:LIN), the leading provider of home respiratory care in the U.S., stands as a second line of defense in support of efforts to address the COVID-19 (coronavirus) public healthcare crisis. Throughout this pandemic, Lincare remains committed to:

– Ensuring continued care to 1.6 million patients across the U.S. supported by more than 2,000 Lincare clinicians.

– Providing in-home services to patients with underlying chronic medical conditions who may be more vulnerable when contracting COVID-19.

– Helping to increase critical hospital capacity by transitioning respiratory patients and others from in-patient to in-home care.

Lincare, a subsidiary of Linde (NYSE:LIN; FWB:LIN) is playing a critical role in caring for patients at home, including some who have tested positive for COVID-19. The company is helping to ease the burden on hospitals across the country by partnering with them to transition patients who are eligible for in-home care, which results in additional hospital capacity for patients requiring critical care. Lincare patients who have tested positive for COVID-19 have received respiratory services including oxygen and nebulized respiratory medications, as well as ventilation services.

"Lincare is well-prepared to safely and reliably provide critical in-home services throughout the COVID-19 pandemic," said Lincare CEO Crispin Teufel. "As a leader in the homecare industry, Lincare is taking all necessary steps to play an active role in fighting this pandemic as a trusted provider for our patients. This includes adhering to industry standards and protocols to help ensure the safety of our patients and our employees. We stand with our fellow healthcare providers – doctors, nurses, caregivers, and clinical staff who are dedicated to providing an excellent standard of care to patients nationwide."

About Lincare

Lincare is the largest U.S. provider of respiratory care in the home with a broad geographic reach, offering an extensive portfolio of quality products and services: Respiratory Therapy, Sleep Therapy, INR Testing, Nebulizer and Respiratory Medications, Enteral Therapy, and Durable Medical Equipment. Lincare's mission is to set the standard for excellence, transforming the way respiratory care is delivered in the home. We are inspired by a vision to enable patients with chronic conditions to remain engaged in life, with the peace of mind that we are caring for them. Visit www.lincare.com.

Further information, email: MediaRelations@Lincare.com

About Linde

Linde is a leading global industrial gases and engineering company with 2019 sales of $28 billion (€25 billion). We live our mission of making our world more productive every day by providing high-quality solutions, technologies and services which are making our customers more successful and helping to sustain and protect our planet.

The company serves a variety of end markets including aerospace, chemicals, food and beverage, electronics, energy, healthcare, manufacturing and primary metals. Linde's industrial gases are used in countless applications, from life-saving oxygen for hospitals to high-purity & specialty gases for electronics manufacturing, hydrogen for clean fuels and much more. Linde also delivers state-of-the-art gas processing solutions to support customer expansion, efficiency improvements and emissions reductions.

For more information about the company and its products and services, please visit www.linde.com.

Language: English Company: Linde plc   The Priestley Centre, 10 Priestley Road   GU2 7XY Guildford   United Kingdom Phone: +1-203-837-2210 E-mail: Investor_Relations@Linde.com Internet: www.linde.com ISIN: IE00BZ12WP82 WKN: A2DSYC Indices: DAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Moscow, NYSE, Luxembourg Stock Exchange (Euro MTF) EQS News ID: 1007169

SOURCE: Linde plc

ReleaseID: 582518

Findit Featured Member NutraCap Labs Offers Supplement Formulation Services To Individuals Looking To Start Their New Supplement Line From Home

ATLANTA, GA / ACCESSWIRE / March 25, 2020 / Findit, Inc. (OTC PINK:FDIT) owner of Findit.com®, a full service social networking management platform that provides a full line of marketing services, is featuring Findit member NutraCap Labs, a premier private label supplements manufacturer offering custom supplement formulation services. Individuals who may be at home who are looking to supplement their income can start their own private label supplement line with NutraCap Labs.

NutraCap Labs is the premier private label supplements manufacturer in Norcross GA offering superior custom supplement formulation services along with private labeling. NutraCap Labs' Norcross facility is over 300k square feet containing high quality raw materials and heavy machinery, allowing them to quickly produce virtually any custom formulated supplement with new private labels. Moreover, they require low purchase minimums which allows individuals and businesses looking to start their own private label supplement business the ability to do so without as much of an upfront investment. As your business grows, NutraCap Labs can scale production of your products as needed.

Findit provides online marketing services to NutraCap Labs through social media marketing to help increase overall online presence and exposure in search engines for the keywords corresponding to the services they provide. This is done through NutraCap Labs Findit URLs that they have claimed using Findit's Claim Your Name Tool. To date, NutraCap Labs has claimed 7 Findit Names. Each of the names represents keywords or phrases that NutraCap Labs is looking to gain exposure for in search engines. The type of content that is created includes picture galleries, video production, social network marketing and sharing to various social sites, right now status updates through their Findit Urls and more.

https://www.youtube.com/watch?v=4XcHFZ43qLk&feature=emb_logo

Visit NutraCap Labs on Findit at findit.com/private-label-supplements. The Claim Your Name Feature on Findit lets you reserve as many names or phrases that you would like and only exist once on Findit.

Check Out NutraCap Labs Latest Posts on Findit

Supplement Manufacturer NutraCap Labs offers private label supplement manufacturing services

Work with the best supplement manufacturer NutraCap Labs for your private label supplements

Get the best private label supplement manufacturing services with NutraCap Labs

Founder John Wes houser invites you to tour their facility in Norcross Georgia. With industry best lead times and low bottle minimums, it is easy to get started today while you may be home with their formulation experts on your very own private label supplements.

Visit NutraCap Labs online at Nutracapusa.com

Watch NutraCap Labs Latest Video on Youtube

https://www.youtube.com/watch?v=7jY9qDWwUnA

Create your own private label supplement business with NutraCap Labs today by calling 800-688-5956.

Findit focuses on reaching the target demographics for each of these members that may or may not be aware of them in an effort to heighten brand awareness of their services and in some cases, their extensive product lines.

About NutraCap Labs

NutraCap Labs' mission is to provide our customers with the highest quality products and an industry-best customer service experience. Based in Atlanta, GA, NutraCap Labs is a manufacturer of Nutraceuticals/Dietary Supplements and we are experiencing explosive growth. As a GMP compliant and an FDA registered company, we specialize in encapsulation manufacturing, sports nutrition and raw health powders, product formulation, brand design and distribution. Private Label manufacturing is the fastest growing sector of our business and our biggest strength due to the relationships we have built with our customers.

Our goal at NutraCap Labs is to partner with our customers to create the best products possible through custom formulation, in-house label design and other services that we offer. Additionally, through our sister company, Active Sports Distribution, we market and sell some of the health and fitness industry's most popular supplements to retail stores worldwide. With the Nutraceutical industry approaching $85 billion annually, we are excited to become a leader in this arena. Our experienced management team is committed to bringing ethics and professionalism to the forefront of the industry.

https://www.youtube.com/watch?v=Gzk0QVArJQU

About Findit, Inc.

Findit.com which is a Social Media Content Management Platform that provides an interactive search engine for all content posted in Findit to appear in Findit search. The site is an open platform that provides access to Google, Yahoo, Bing and other search engines access to its content posted to Findit so it can be indexed in these search engines as well. Findit provides Members the ability to post, share and manage their content. Once they have posted in Findit, we ensure the content gets indexed in Findit Search results. Findit provides an option for anyone to submit URLs that they want indexed in Findit search result, along with posting status updates through Findit Right Now. Status Updates posted in Findit can be crawled by outside search engines which can result in additional organic indexing. All posts on Findit can be shared to other social and bookmarking sites by members and non-members. Findit provides Real Estate Agents the ability to create their own Findit Site where they can pull in their listing and others through their IDX account. Findit, Inc., is focused on the development of monetized Internet-based web products that can provide an increase in brand awareness of our members. Findit, Inc., trades under the stock symbol FDIT on the OTCPinksheets.

Safe Harbor:

This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding potential sales, the success of the company's business, as well as statements that include the word believe or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Findit, Inc. to differ materially from those implied or expressed.

CONTACT:

Clark St. Amant
404-443-3224

SOURCE: Findit, Inc.

ReleaseID: 582512

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CPI Aerostructures, Inc. (CVU)

LOS ANGELES, CA / ACCESSWIRE / March 25, 2020 / Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming April 24, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of CPI Aerostructures, Inc. ("CPI or the "Company") (NYSE:CVU) securities between May 15, 2018 and February 14, 2020 inclusive (the "Class Period").

If you suffered a loss on your CPI investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information here or contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, via email shareholders@glancylaw.com or visit our website at www.glancylaw.com to learn more about your rights.

On February 8, 2019, CPI announced that its previously issued financial statements for the three and nine months ended September 30, 2018 should no longer be relied upon due to an error related to the Company's billing process which caused an overstatement of revenue.

On this news, CPI's share price fell 8.5% to close at $6.34 per share on February 8, 2019, thereby injuring investors.

Then, on February 14, 2020, CPI announced that its financial statements for fiscal 2018 and 2019 should no longer be relied upon because "certain revenues and net income were recognized prematurely or inaccurately." Additionally, the Company announced that its Chief Financial Officer had resigned.

On this news, the Company's stock price fell $1.80, or nearly 27%, to close at $4.87 per share on February 14, 2020, thereby injuring investors further.

The complaint alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) CPI Aerostructures' financial statements included in its Forms 10-Q for the first, second, and third quarters of 2018 and of 2019 incorrectly applied generally accepting accounting principles and thus revenue, net income, retained earnings, and contract assets were overstated; (2) as a result, the financial statements included in the Form 10-Qs for 2018 and for 2019 and the annual report on Form 10-K for 2018 could no longer be relied upon and required restatement; (3) CPI Aerostructures lacked adequate internal controls over financial reporting and effective disclosure controls and procedures as of the period during each reporting period of 2018; (4) CPI Aerostructures lacked effective disclosure controls and procedures during the third quarter of 2019; and (5) as a result, CPI Aerostructures' public statements were materially false and/or misleading at all relevant times.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired CPI securities during the Class Period, you may move the Court no later than April 24, 2020 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

CONTACT:

Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com

SOURCE: Glancy Prongay & Murray LLP

ReleaseID: 582370

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Canaan Inc. (CAN)

BENSALEM, PA / ACCESSWIRE / March 25, 2020 /­ Law Offices of Howard G. Smith reminds investors of the upcoming May 4, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired of Canaan Inc. ("Canaan" or the "Company") (NASDAQ:CAN ) securities pursuant and/or traceable to the Company's initial public offering commenced on or about November 20, 2019.

Investors suffering losses on their Canaan investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.

In November 2019, Canaan completed its initial public offering ("IPO"), issuing 10 million American Depositary Shares ("ADSs"), at $9.00 per share.

On February 20, 2020, after market closed, Marcus Aurelius published a report entitled "Canaan Fodder" alleging, among other things, that Canaan was engaged in several undisclosed related-party transactions that lacked economic substance.

On this news, the Canaan's ADSs fell $0.39 per ADS, or nearly 7%, to close at $5.32 per share on February 20, 2020, thereby injuring investors. Since the IPO, Canaan's stock has traded as low as $5.72 per share, significantly below the $9 offering price.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the purported "strategic cooperation" with Hangzhou Grandshores Weicheng Technology Co., Ltd. was actually a transaction with a related party; (2) that the company's financial health was worse than what was actually reported; (3) that the company had recently removed numerous distributors from its website just prior to the IPO, many of which were small or suspicious businesses; and (4) that several of the Company's largest Chinese clients in prior years were clients who were not in the Bitcoin mining industry and, thus, would likely not be repeat customers.

If you purchased Canaan securities during the Class Period, you may move the Court no later than May 4, 2020 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

CONTACT:

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

SOURCE: Law Offices of Howard G. Smith

ReleaseID: 582369

Renowned Architect David Hovey’s First Private Residential Design and Former Home Shadow Caster Hits the Market in Desert Mountain

SCOTTSDALE, AZ / ACCESSWIRE / March 25, 2020 / Russ Lyon Sotheby's International Realty has announced ​Shadow Caster​, the first private home designed by architect David Hovey, has hit the market. The former desert home of the renowned architect is one of just five in Arizona designed by Hovey. Listed at $5.3 million, it's a rare opportunity to own a contemporary masterpiece in ​Desert Mountain​, one of the finest golf and recreational communities in North Scottsdale.

One of just five Hovey-designed homes in Arizona, the contemporary residence is listed for $5.3 million, offering a
rare opportunity to own a one-of-a-kind masterpiece.

Located on a lot handpicked by David Hovey and on one of the best homesites in the Saguaro Forest neighborhood of Desert Mountain, Shadow Caster is an architecturally significant home. Designed by renowned architect David Hovey and constructed by Optima Development, both responsible for the various Optima developments throughout greater Phoenix and Chicago, Shadow Caster was Hovey's first private home which he designed for himself and his family in 2001. Built into ancient boulders, it's nestled above the 8th green of the Chiricahua golf course, offering panoramic views of the city lights, mountains and golf course.

Laid out like a pinwheel, the 6,852-sq.-ft. home features floor-to-ceiling glass windows, honed aggregate concrete block and exposed steel beams. The five-bedroom, five-and-one-half bathroom home consists of a main house and a detached guest house accessed via walkway. Notable features include stainless steel kitchen countertops, privacy shades on all windows, stained and polished concrete floors, corrugated steel ceilings, indigenous botanical gardens, a floating staircase and glass floor balconies. Several outdoor features include a heated pool and spa and spacious outdoor living areas.

"Shadow Caster does not try to disappear into the desert; rather it looks exactly like the carefully conceived, harmoniously structured intervention it is," notes author Cheryl Kent in ​Shadow Caster​, her book showcasing the intricate details of the home.

Made entirely of steel, concrete and glass, Shadow Caster was thoughtfully designed to take the movement of the day's light into consideration, optimizing its livability through all seasons. For example, on the east and west end of the house where sun exposure is most prominent, the walls are made of insulated masonry which is slow to absorb heat, keeping the home cool in the day and warm at night. The home's unique bridge structure creates a shaded area, making it possible to be outdoors during summer days and the south terrace's sun exposure extends outdoor use through the winter.

"This is what I imagined when I saw the site. I was captivated by the concept of the house straddling the mounds on either side with open space underneath," says Hovey, as quoted in ​Shadow Caster​.

The home's modern design was so far ahead of its time that when Hovey was building it in 2001, Desert Mountain's design committee couldn't quite grasp it. After flying the entire team to Chicago, Hovey successfully presented his concept to the committee where they then approved the designs. Today, there are a total of five homes in Desert Mountain that Hovey has designed, including his current personal residence.

David Hovey is a Fellow of The American Institute of Architects (FAIA), the highest membership honor for AIA members and is also the founder and CEO of Optima, Inc. Since founding the development, design and construction company in 1978, Hovey has overseen the construction of more than 6,000 condominium and apartment units across Chicago, Phoenix and Scottsdale, along with several private residential homes.

See more of Shadow Caster in a video ​here​.

Shadow Caster is listed by Shawn Chappel and Cheryl D'Anna of Russ Lyon Sotheby's International Realty.

Desert Mountain

Desert Mountain is an 8,000-acre luxury lifestyle and private golf community in the elevated foothills of North Scottsdale. Home to six Jack Nicklaus Signature Golf Courses and a new championship course, an award-winning Sonoran spa and fitness center, ten restaurants and grills, tennis and pickleball courts and dozens of private hiking and biking trails, Desert Mountain is the epitome of luxury desert living. Real estate opportunities comprise custom residences, estates and courtyard homes tucked into a premier collection of secluded villages. ​desertmountain.com​.

CONTACT: 

Shawn Chappel
shawn.chappel@russlyon.com
480-329-2020

Chery D'Anna
chery.danna@russlyon.com
480-319-3800

SOURCE: Cheryl D’Anna of Russ Lyon Sotheby’s International Realty

ReleaseID: 582308